25.73

5.93% -1.43

Anbio Biotechnology (NNNN)

Overview News Price History Discussions Forecast

Anbio Biotechnology stock is traded at $25.73, with a volume of 85,493. It is down -5.93% in the last 24 hours and down -28.41% over the past month. Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Previous Close:

$27.16

Open:

$27.17

24h Volume:

85,493

Relative Volume:

1.84

Market Cap:

$1.13B

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+6.19%

1M Performance:

-28.41%

6M Performance:

-46.41%

1Y Performance:

+0.00%

1-Day Range:

$25.51

$27.49

1-Week Range:

$21.09

$28.00

52-Week Range:

$5.60

$55.65

Anbio Biotechnology Stock (NNNN) Company Profile

Name

Anbio Biotechnology

Sector

Healthcare (1118)

Industry

Medical Instruments & Supplies (58)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

NNNN's Discussions on Twitter

Compare NNNN vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NNNN Anbio Biotechnology	25.69	1.19B	0	0	0	0.00
ISRG Intuitive Surgical Inc	479.80	176.19B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	178.52	51.41B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	78.63	39.00B	10.19B	1.05B	1.38B	2.1044
MDLN Medline Inc	43.73	37.48B	27.43B	1.27B	1.01B	1.5829
RMD Resmed Inc	246.69	37.82B	5.40B	1.49B	1.78B	10.12

Anbio Biotechnology Stock (NNNN) Latest News

03:46 AM

Head to Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

03:46 AM

03:11 AM

COREwafer Industries Inc. (OTCMKTS:AHIX) Short Interest Up 126.9% in January - Defense World

03:11 AM

03:01 AM

GRAIL (GRAL) Projected to Post Earnings on Thursday - Defense World

03:01 AM

Feb 11, 2026

Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Feb 11, 2026

Feb 10, 2026

Financial Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Feb 10, 2026

Financial Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Feb 10, 2026

Feb 08, 2026

Critical Analysis: Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Feb 08, 2026

Feb 05, 2026

InvestingPro’s overvalued warning saved investors from 54% Anbio Bio crash By Investing.com - Investing.com South Africa

Jan 28, 2026

Jan 26, 2026

Intel, Oracle among market cap stock movers on Monday By Investing.com - Investing.com Nigeria

Jan 26, 2026

Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair - TipRanks

Jan 26, 2026

Anbio Biotechnology Announces Board and Committee Changes, Effective January 21, 2026 - marketscreener.com

Jan 26, 2026

Jan 22, 2026